HURDLES TO REIMBURSEMENT FOR GLP-1 THERAPIES IN WEIGHT MANAGEMENT

被引：0
|
作者：
Stanley, A. [1 ]
Nisar, S. [2 ]
Rowlands, C. [2 ]
机构：
[1] Envis Pharma Grp, London, England
[2] Envis Pharma Grp, Horsham, W Sussex, England
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA7
引用
收藏
页码：S354 / S354
页数：1
相关论文
共 50 条
  • [41] Role of Dual GIP and GLP-1 Receptor Agonist, Tirzepatide in the Management of Weight Loss; A Systematic Review
    Rangraze, Imran Rashid
    Khan, Shehla
    Wali, Adil Farooq
    Menezes, Godfred
    Goud, Manjunatha
    Jabran, Muhammad
    CURRENT DRUG SAFETY, 2024,
  • [42] ASSESSING THE CONTINUATION OF GLP-1 WHEN WEIGHT AND A1C ARE NOT REDUCED
    Duncan, K.
    Swislocki, A.
    Zhou, R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (01) : 70 - 70
  • [43] GLP-1 release in obese subjects before and after weight loss and weight maintenance
    Adam, T
    Westerterp-Plantenga, M
    INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S175 - S175
  • [44] Glucagon-like peptide 1 (GLP-1) analogues and weight loss
    不详
    ARCHIVES OF DISEASE IN CHILDHOOD, 2020, 105 (07) : 663 - 663
  • [45] Distinct activation of GLP-1 receptor by exendin-4 and GLP-1
    Montrose-Rafizadeh, C
    Yang, H
    Pritchette, LA
    Eng, J
    DIABETES, 1998, 47 : A192 - A192
  • [46] Pulmonary administration of GLP-1 (GLP-1 Technosphere powder) I: Kinetics
    Cassidy, J.
    Baughman, R.
    Costello, D.
    Levy, B.
    van Vliet, A.
    Diaz, M.
    Damico, C.
    Richardson, P.
    DIABETOLOGIA, 2008, 51 : S346 - S346
  • [47] Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function
    Marathe, Chinmay S.
    Rayner, Christopher K.
    Jones, Karen L.
    Horowitz, Michael
    EXPERIMENTAL DIABETES RESEARCH, 2011,
  • [48] COMPARISON OF THERAPIES WITH GLP-1 ANALOGUES IN PATIENTS WITH UNCONTROLLED TYPE 2 DIABETES
    Abreu Lomba, A.
    Rios, C.
    Zambrano, J.
    Buitrago, N.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A180 - A181
  • [49] Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss
    Reiss, Allison B.
    Gulkarov, Shelly
    Lau, Raymond
    Klek, Stanislaw P.
    Srivastava, Ankita
    Renna, Heather A.
    De Leon, Joshua
    BIOMOLECULES, 2025, 15 (03)
  • [50] Therapeutic approach of type 2 diabetes mellitus with GLP-1 based therapies
    Penfornis, A.
    Borot, S.
    Raccah, D.
    DIABETES & METABOLISM, 2008, 34 : S78 - S90
12345